Literature DB >> 11911483

The effect of tumour size on ferromagnetic embolization hyperthermia in a rabbit liver tumour model.

P Moroz1, S K Jones, B N Gray.   

Abstract

OBJECTIVE: Ferromagnetic Embolization Hyperthermia (FEH) consists of arterially embolizing tumours with ferromagnetic particles to cause hysteretic heating upon subsequent exposure to an alternating magnetic field. The objective was to determine the effect of tumour size during FEH using a rabbit liver tumour model.
METHOD: Thirty-three rabbits containing implanted hepatic VX2 carcinomas received a hepatic arterial infusion of ferromagnetic particles suspended in lipiodol. Following hysteretic heating, tumour and normal hepatic tissues were chemically analysed for iron content. Tumours were classed as small if their mass was less than the median mass for the whole group of subjects (2.1 g), and as large if their mass was greater than or equal to the median. To control for variability in tumour iron concentration, 13 small tumours were matched to 13 large tumours by iron concentration, and their heating characteristics compared.
RESULTS: The heating rate in large tumours (median = 5.0 degrees C/min) was significantly greater than that in the matched small tumours (median = 2.8 degrees C/min), p = 0.006. Regression analysis determined that the slope of the heating rate vs iron concentration curve for large tumours was 1.5 times greater than that for the matched small tumours, p < 0.001. After cessation of heating in large tumours, there was continued heat dissipation into surrounding tissues, which led to anomalous temperature increases. There was an inverse linear relationship between tumour size and tumour iron concentration for a given dose of particles.
CONCLUSION: For a given tumour iron concentration, larger tumours heat at a greater rate than small tumours, due to the poorer tissue cooling and better heat conduction in the necrotic regions of large tumours. This warrants further investigation as this finding could confer a significant advantage on FEH over other hyperthermic modalities in the treatment of hepatic malignancies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911483     DOI: 10.1080/02656730110095609

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  10 in total

1.  Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study.

Authors:  Anilchandra Attaluri; Madhav Seshadri; Sahar Mirpour; Michele Wabler; Thomas Marinho; Muhammad Furqan; Haoming Zhou; Silvia De Paoli; Cordula Gruettner; Wesley Gilson; Theodore DeWeese; Monica Garcia; Robert Ivkov; Eleni Liapi
Journal:  Int J Hyperthermia       Date:  2016-05-05       Impact factor: 3.914

2.  Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field.

Authors:  Kyoung Ah Min; Faquan Yu; Victor C Yang; Xinyuan Zhang; Gus R Rosania
Journal:  Pharmaceutics       Date:  2010-04-26       Impact factor: 6.321

3.  Microfluidic fabrication of 6-methoxyethylamino numonafide-eluting magnetic microspheres.

Authors:  D-H Kim; T Choy; S Huang; R M Green; R A Omary; A C Larson
Journal:  Acta Biomater       Date:  2013-10-23       Impact factor: 8.947

4.  Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells.

Authors:  Zi-Yu Wang; Jian Song; Dong-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

5.  The Synergistic Effect of Hyperthermia and Chemotherapy in Magnetite Nanomedicine-Based Lung Cancer Treatment.

Authors:  Shu-Jyuan Yang; Chung-Huan Huang; Chung-Hao Wang; Ming-Jium Shieh; Ke-Cheng Chen
Journal:  Int J Nanomedicine       Date:  2020-12-18

6.  Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.

Authors:  Hui Yu; Guang-Yu Zhu; Rui-Zhi Xu; Huan-Zhang Niu; Qin Lu; Guo-Zhao Li; Zi-Yu Wang; Dong-Sheng Zhang; Ning Gu; Gao-Jun Teng
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

7.  Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines.

Authors:  Xiao-Ming Zhu; Yi-Xiang J Wang; Ken Cham-Fai Leung; Siu-Fung Lee; Feng Zhao; Da-Wei Wang; Josie M Y Lai; Chao Wan; Christopher H K Cheng; Anil T Ahuja
Journal:  Int J Nanomedicine       Date:  2012-02-21

8.  Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumor model.

Authors:  Hongliang Sun; Linfeng Xu; Tianyuan Fan; Hongzhi Zhan; Xiaodong Wang; Yanfei Zhou; Ren-jie Yang
Journal:  Int J Nanomedicine       Date:  2013-10-02

9.  Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.

Authors:  Yiqun Du; Dongsheng Zhang; Hui Liu; Rensheng Lai
Journal:  BMC Biotechnol       Date:  2009-10-05       Impact factor: 2.563

10.  Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality.

Authors:  Lauren E Woodard; Cindi L Dennis; Julie A Borchers; Anilchandra Attaluri; Esteban Velarde; Charlene Dawidczyk; Peter C Searson; Martin G Pomper; Robert Ivkov
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.